4089
Budget impact analysis of ipilimumab usage in patients with metastatic melanoma
Melanoma is a malignant tumor that develops from transformed melanocytes, located mainly in the skin. According to Russian statistics, the incidence of melanoma in 2014 was 9,390 new cases [4]. In 2004-2014, melanoma prevalence rate per 100,000 population increased on average by 4.2% per year. High prevalence of melanoma and frequent poor prognosis necessitate search of innovative treatment methods and use of high-tech drugs.
Скорее всего ваш браузер не поддерживает PDF и Adobe Reader, нажмите здесь, чтобы просмотреть PDF
Bibliography link:
Kulikov A.Yu., Skripnik A.R. Budget impact analysis of ipilimumab usage in patients with metastatic melanoma // Pharmacoeconomics: theory and practice. - 2016. - Vol.4, №3. - P.74-77 DOI: https://doi.org/10.30809/phe.3.2016.2
Comments0